Isobel Walker

Director
UK NEQAS BC

Presentation(s):

• OC 17.5 - Direct Oral Anti-Coagulant (DOAC) external quality assessment (EQA) scheme assay results and interpretations from UKNEQAS BC DOAC Survey 19 2021.

  Sunday, July 10, 2022
  11:45 AM – 12:00 PM

• PB1075 - Discrepant results for ADAMTS13 assays with different activity assays. Artefact or cause for concern?

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1079 - Effect of anti -factor Xa direct oral anticoagulants (DOACs) on viscoelasticity measurements in External Quality Assessment (EQA) samples: UK NEQAS BC experience

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1100 - Vaccine Induced Immune Thrombocytopenia and Thrombosis (VITT) external quality assessment (EQA) scheme results and interpretations from a joint UKNEQAS BC, SSC and ECAT VITT Survey May 2021.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1101 - Measurement of fibrinogen using two concentrations of Thrombin with patients receiving Argatroban or normal plasma spiked with Argatroban: a review of UK NEQAS (Blood Coagulation) exercises 2021.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM